Prevalence, Age And Gender Determinants, Temporal Trends, and Viral Subtypes of Hepatitis Infection among Patients Attending Maklin Clinic and Maternity, Garaku, Kokona Lga, Nasarawa State, Nigeria (2022–2024)

Viral hepatitis remains a major public health challenge in Nigeria, contributing significantly to chronic liver disease, cirrhosis, and hepatocellular carcinoma. Despite national seroprevalence surveys, localized facility-based epidemiological data remain scarce in semi-urban communities of North-Central Nigeria. This retrospective cross-sectional study assessed hepatitis prevalence, age and gender determinants, viral subtypes, and temporal trends among patients attending Maklin Clinic and Maternity, Garaku, Kokona LGA, Nasarawa State, between January 2022 and December 2024.

Hepatitis, Prevalence, Nigeria, Age Stratification, Gender, Viral Subtype, Temporal Trend, Epidemiology

1. Adewuyi, O. S., Akinyemi, J. O., et al. (2025). Molecular epidemiology, drug-resistant variants, and transmission dynamics of hepatitis B virus in Nigeria. Pathogens, 14(1), 101. [Google Scholar] [Crossref]

2. Agboeze, J., et al. (2023). Hepatitis B virus seroprevalence and potential perinatal transmission among rural pregnant women in Nigeria. Nigerian Medical Journal. [Google Scholar] [Crossref]

3. Akabuike, O. M. A., Nwankwo, C. C., et al. (2024). Evaluating hepatitis B screening, prevalence, vaccination uptake and linkage to care in Nigerian communities. BMC Public Health, 24, 21017. [Google Scholar] [Crossref]

4. Ajuwon, B. I., Yujuico, I., Roper, K., Richardson, A., Sheel, M., & Lidbury, B. A. (2021). Hepatitis B virus infection in Nigeria: A systematic review and meta-analysis of data published between 2010 and 2019. BMC Infectious Diseases, 21(1), Article 1120. https://doi.org/10.1186/s12879-021-06800-6 [Google Scholar] [Crossref]

5. Aliyu, A. A. (2024). Prevalence of Hepatitis B infection among patients attending the University Health Clinic, Nasarawa State University, Keffi, Nigeria. African Journal of Clinical and Medical Sciences. [Google Scholar] [Crossref]

6. Ali, N., Kasali, A. T., Sani, M., Aliyu, I. R., & Abubakar, B. S. (2024). Epidemiology of Hepatitis B Virus among women receiving antenatal care at General Hospital Keffi, Nasarawa State, Nigeria. Journal of Health Systems Research, 6(3). [Google Scholar] [Crossref]

7. . Angbalaga GA, Shohaimi S, Mohd Nadzir MNH, Ab Rahman AH. Prevalence and Associated Risk Factors of Hepatitis B Virus Infection in Lafia Metropolis, Nasarawa State, Nigeria (2024). [Google Scholar] [Crossref]

8. Asaolu, O. I., et al. (2024). Hepatitis B virus serology among first-degree relatives and spouses of patients with hepatocellular carcinoma in Lagos, Nigeria. Nigerian Journal of Gastroenterology and Hepatology, 16(1), 1–10. [Google Scholar] [Crossref]

9. Ashaka, O., et al. (2024). Prevalence and risk implications of hepatitis B and C infections among university students in Lagos State, Nigeria. Babcock University Medical Journal, 7(1), 1–11. [Google Scholar] [Crossref]

10. Blach, S., Terrault, N. A., Tacke, F., Gamkrelidze, I., Craxì, A., Tanaka, J., Waked, I., Dore, G. J., & Razavi, H. (2023). Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2022. Journal of Hepatology, 79(4), 1040–1052. [Google Scholar] [Crossref]

11. Bonita, R., Beaglehole, R., & Kjellström, T. (2006). Basic epidemiology (2nd ed.). World Health Organization. [Google Scholar] [Crossref]

12. Burki, T. (2024). WHO's 2024 Global Hepatitis Report. The Lancet Infectious Diseases, 24(6), e362–e363. [Google Scholar] [Crossref]

13. Egbe KA, Ike A, Egbe F. Knowledge and Burden of Hepatitis B Virus in Nasarawa State, Nigeria (2023). [Google Scholar] [Crossref]

14. Federal Ministry of Health. (2022). National strategic plan for viral hepatitis control in Nigeria. Abuja, Nigeria. [Google Scholar] [Crossref]

15. Federal Ministry of Health. (2022). National viral hepatitis seroprevalence survey report. Abuja, Nigeria. [Google Scholar] [Crossref]

16. Field, A. (2018). Discovering statistics using IBM SPSS statistics (5th ed.). Sage Publications. [Google Scholar] [Crossref]

17. Garbati, M., et al. (2024). Sero-prevalence of hepatitis B and C among undergraduate students in North-East Nigeria. Nigerian Medical Journal, 65(2), 115–123. [Google Scholar] [Crossref]

18. Hiebert-Suwondo, L., et al. (2025). A global report on national policy, programmes and progress towards hepatitis B elimination. The Lancet Gastroenterology & Hepatology, 10(2), 95–107. [Google Scholar] [Crossref]

19. Levin, K. A. (2006). Study design III: Cross-sectional studies. Evidence-Based Dentistry, 7(1), 24–25. https://doi.org/10.1038/sj.ebd.6400375 [Google Scholar] [Crossref]

20. Lemoine, M., Eholié, S., & Lacombe, K. (2018). Reducing the neglected burden of viral hepatitis in Africa. The Lancet Gastroenterology & Hepatology, 3(4), 275–284. [Google Scholar] [Crossref]

21. Mann, C. J. (2003). Observational research methods: Research design II: Cohort, cross-sectional, and case-control studies. Emergency Medicine Journal, 20(1), 54–60. https://doi.org/10.1136/emj.20.1.54 [Google Scholar] [Crossref]

22. Musa, B. M., Bussell, S., Borodo, M. M., Samaila, A. A., & Femi, O. L. (2018). Prevalence of hepatitis B virus infection in Nigeria, 2000–2017: A systematic review and meta-analysis. Nigerian Journal of Clinical Practice, 21(10), 1230–1238. [Google Scholar] [Crossref]

23. Mbituyumuremyi, A., et al. (2021). Hepatitis B virus infection and associated factors in Sub-Saharan Africa: A systematic review. BMC Infectious Diseases, 21(1), 1–15. [Google Scholar] [Crossref]

24. Ndubuisi, J. C., Akinyemi, O., & colleagues. (2022). Prevalence of Hepatitis B Virus among students of Faculty of Applied and Natural Sciences, Nasarawa State University, Keffi, Nigeria. South Asian Journal of Parasitology, 5(2), 1–8. [Google Scholar] [Crossref]

25. Nwokediuko, S. C. (2020). Chronic hepatitis B in Nigeria: Challenges and future directions. Nigerian Medical Journal, 61(1), 1–6. [Google Scholar] [Crossref]

26. Owoseni MC, Sani BE, Usman HD. Seroprevalence and Risk Factors of Hepatitis B and C Virus Infection among Inmates in a Correctional Service, Nasarawa State, Nigeria (2023). [Google Scholar] [Crossref]

27. Olakunde, B. O., et al. (2025). Epidemiology of hepatitis B virus infection in Nigeria: A review of prevalence trends and public health implications. Journal of Tropical Medicine. [Google Scholar] [Crossref]

28. Olayinka, A. T., Oyemakinde, A., Balogun, M. S., et al. (2016). Seroprevalence of hepatitis B infection in Nigeria: A national survey. American Journal of Tropical Medicine and Hygiene, 95(4), 902–907. [Google Scholar] [Crossref]

29. Oti VB et al. Hepatitis B Virus Infection Prevalence among Patients in a Local Community Hospital in Nasarawa State, Nigeria (2021). [Google Scholar] [Crossref]

30. Pallant, J. (2020). SPSS survival manual (7th ed.). McGraw-Hill Education. [Google Scholar] [Crossref]

31. Polaris Observatory Collaborators. (2022). Global prevalence, treatment and prevention of hepatitis B virus infection in 2022. The Lancet Gastroenterology & Hepatology, 7(9), 796–829. [Google Scholar] [Crossref]

32. Prevalence and Risk Factors of Hepatitis B Virus Infection among Patients in Tertiary Healthcare Facilities in Nasarawa State, Nigeria (2025). [Google Scholar] [Crossref]

33. Razavi, H., Blach, S., Terrault, N. A., et al. (2023). Global hepatitis elimination: Progress and remaining challenges. Hepatology, 77(2), 567–579. [Google Scholar] [Crossref]

34. Riou, J., Aït Ahmed, M., Blake, A., et al. (2016). Hepatitis C virus seroprevalence in adults in Africa: A systematic review and meta-analysis. Journal of Viral Hepatitis, 23(4), 244–255. [Google Scholar] [Crossref]

35. Rothman, K. J., Greenland, S., & Lash, T. L. (2021). Modern epidemiology (4th ed.). Wolters Kluwer. [Google Scholar] [Crossref]

36. Shimakawa, Y., Njie, R., Ndow, G., et al. (2020). Prevention of mother-to-child transmission of hepatitis B in Africa. The Lancet Gastroenterology & Hepatology, 5(10), 981–986. [Google Scholar] [Crossref]

37. Spearman, C. W., Dusheiko, G. M., Hellard, M., & Sonderup, M. W. (2017). Hepatitis B in Sub-Saharan Africa: Strategies to achieve the 2030 elimination targets. The Lancet Gastroenterology & Hepatology, 2(12), 900–909. [Google Scholar] [Crossref]

38. Stanaway, J. D., Flaxman, A. D., Naghavi, M., et al. (2016). The global burden of viral hepatitis from 1990 to 2013. The Lancet, 388(10049), 1081–1088. [Google Scholar] [Crossref]

39. Shuaib, B. I., et al. (2024). Prevalence of overt and occult hepatitis B viral infection among Nigerian populations. BMC Infectious Diseases, 24(1), 1254. [Google Scholar] [Crossref]

40. Setia, M. S. (2016). Methodology series module 3: Cross-sectional studies. Indian Journal of Dermatology, 61(3), 261–264. [Google Scholar] [Crossref]

41. Wang, X., & Cheng, Z. (2020). Cross-sectional studies: Strengths, weaknesses and recommendations. Chest, 158(1 Suppl.), S65–S71. [Google Scholar] [Crossref]

42. Wong, G. L. H., Sarin, S. K., Kumar, M., et al. (2025). Updated WHO guidelines for prevention and treatment of hepatitis B and C. Journal of Hepatology, 82(1), 15–30. [Google Scholar] [Crossref]

43. World Health Organization. (2024). Global hepatitis report 2024. Geneva: World Health Organization. [Google Scholar] [Crossref]

44. World Health Organization. (2024). Hepatitis B fact sheet. Geneva: World Health Organization. [Google Scholar] [Crossref]

45. World Health Organization. (2024). Hepatitis C fact sheet. Geneva: World Health Organization. [Google Scholar] [Crossref]

46. World Health Organization Regional Office for Africa. (2024). Hepatitis in Africa: Epidemiological update. Brazzaville: WHO Regional Office for Africa. [Google Scholar] [Crossref]

47. World Health Organization Regional Office for Africa. (2023). In Nigeria, boosting viral hepatitis awareness and treatment. [Google Scholar] [Crossref]

• Migrant Health in Morocco: Between Law and Reality
• CaknaMinda: An Educator-Centred Mobile App for Early Screening of Mental Health and Schizophrenia Risks
• Health System and Nursing Strategies for Enhancing Male Participation in Family Planning: Evidence from Tema General Hospital, Ghana.
• From Īśvara-Praṇidhāna to Parā-Bhakti: Convergent Paths of Aṣṭāṅga Yoga and Bhakti Yoga
• Evidence-Based Psycho-Oncological Interventions: A Multimodal Approach to Supportive Care